No abstract available
Publication types
-
Comment
-
Historical Article
-
Letter
MeSH terms
-
Aspirin / therapeutic use
-
Cardiovascular Diseases / chemically induced*
-
Celecoxib
-
Cyclooxygenase Inhibitors / adverse effects*
-
Cyclooxygenase Inhibitors / history
-
Drug Approval / history
-
Drug Interactions
-
Gastrointestinal Diseases / chemically induced
-
Gastrointestinal Diseases / history
-
History, 20th Century
-
History, 21st Century
-
Humans
-
Lactones / adverse effects*
-
Lactones / history
-
Platelet Aggregation Inhibitors / therapeutic use
-
Pyrazoles / adverse effects
-
Pyrazoles / history
-
Sulfonamides / adverse effects
-
Sulfonamides / history
-
Sulfones / adverse effects*
-
Sulfones / history
-
United States
-
United States Food and Drug Administration
Substances
-
Cyclooxygenase Inhibitors
-
Lactones
-
Platelet Aggregation Inhibitors
-
Pyrazoles
-
Sulfonamides
-
Sulfones
-
rofecoxib
-
Celecoxib
-
Aspirin